Norovirus Bivalent-Vaccine Efficacy Study

Clinical trial NCT01609257 · COMPLETED

Trial details

NCT number: NCT01609257
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prevention From Norovirus Infection

Start date: 2012-07-16
Primary completion: 2014-03-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.